Xencor, Inc. (XNCR) and Janssen Biotech, a Johnson & Johnson (JNJ) company, have entered into a global collaboration and license agreement to develop …
Xencor presented new data from multiple preclinical studies for XmAb bispecific antibody and its preclinical IL-12-Fc cytokine program at the American Association for …
This week was a busy one for biopharma BD teams. Finallized on Sunday, Valeant (VRX) will pay $158 per share for Salix Pharmaceuticals (SLXP) in an all-cash …
Xencor, Inc (NASDAQ:XNCR) priced an equity financing on Wednesday morning, selling 7.5 million shares of common stock at $14.
In a research report released today, MLV analyst Arlinda Lee initiated coverage on shares of Xencor (NASDAQ:XNCR) with a Buy rating and a …